SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-113103
Filing Date
2018-04-10
Accepted
2018-04-10 17:04:56
Documents
2
Effectiveness Date
2018-04-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d510915ddefa14a.htm DEFA14A 17300
2 GRAPHIC g510915img1.jpg GRAPHIC 264347
  Complete submission text file 0001193125-18-113103.txt   378949
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36644 | Film No.: 18748568
SIC: 2834 Pharmaceutical Preparations